Published in Wien Klin Wochenschr on May 31, 2004
Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Organ (1999) 12.10
The economic burden of malaria. Am J Trop Med Hyg (2001) 11.14
WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet (2004) 9.27
Changing home treatment of childhood fevers by training shop keepers in rural Kenya. Trop Med Int Health (1999) 4.43
The past, present and future of childhood malaria mortality in Africa. Trends Parasitol (2001) 4.10
The "roll back malaria" campaign. Science (1998) 3.27
Roll back malaria? The scarcity of international aid for malaria control. Malar J (2003) 2.17
Impact of increasing consultation fees on malaria in Africa. Wien Klin Wochenschr (2004) 1.56
Atopy and malaria. Wien Klin Wochenschr (2001) 1.48
Will the Global Fund help roll back malaria in Africa? Lancet (2002) 1.43
The management of fevers in Kenyan children and adults in an area of seasonal malaria transmission. Trans R Soc Trop Med Hyg (2004) 1.37
The contribution of health-care services to a sound and sustainable malaria-control policy. Lancet Infect Dis (2003) 1.21
[Malaria therapy in the era of chloroquine resistance]. Wien Klin Wochenschr (1998) 0.84
Europe refuses to match US cash for ailing Global Fund. Lancet (2003) 0.82
Clinical and parasitological response of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in rural Uganda. Wien Klin Wochenschr (2003) 0.81
Antimalarial cocktails--tropical flavours of the month. Lancet (2002) 0.79
Malaria drug-susceptibility testing. HRP2-based assays: current data, future perspectives. Wien Klin Wochenschr (2003) 0.78
A blinded, controlled trial of an ultrasound device as mosquito repellent. Wien Klin Wochenschr (2000) 0.76
Response to accusations of medical malpractice by WHO and the Global Fund. Lancet (2004) 0.75
Financing to Global Fund slashed by the Bush administration. Lancet (2004) 0.75
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis (2008) 2.69
Amplification of Plasmodium falciparum multidrug resistance gene 1 in isolates from Gabon. J Infect Dis (2005) 2.58
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis (2011) 2.54
Fosmidomycin for malaria. Lancet (2002) 2.03
High prevalence of asymptomatic Plasmodium falciparum infection in Gabonese adults. Am J Trop Med Hyg (2007) 1.99
Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial. J Infect Dis (2007) 1.99
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon. J Infect Dis (2008) 1.70
Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study). BMC Infect Dis (2010) 1.57
History and perspectives of medical research at the Albert Schweitzer Hospital in Lambaréné, Gabon. Wien Klin Wochenschr (2007) 1.52
Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. J Infect Dis (2008) 1.51
Socio-economic status is inversely related to bed net use in Gabon. Malar J (2008) 1.46
Artesunate--amodiaquine combination therapy for falciparum malaria in young Gabonese children. Malar J (2007) 1.23
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization. J Infect Dis (2010) 1.21
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial. Clin Infect Dis (2005) 1.18
Short-course artesunate treatment of uncomplicated Plasmodium falciparum malaria in Gabon. Antimicrob Agents Chemother (2003) 1.18
Clinical and parasitological characteristics of puerperal malaria. J Infect Dis (2005) 1.15
Full blood count and haemozoin-containing leukocytes in children with malaria: diagnostic value and association with disease severity. Malar J (2008) 1.12
Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria. Antimicrob Agents Chemother (2007) 1.12
Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon. Malar J (2008) 1.10
New emerging Plasmodium falciparum genotypes in children during the transition phase from asymptomatic parasitemia to malaria. Am J Trop Med Hyg (2002) 1.10
The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial. PLoS One (2013) 1.09
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine. BMC Med (2014) 1.07
Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D). PLoS One (2011) 1.04
No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon. J Infect Dis (2009) 1.01
Epidemiology and population structure of Staphylococcus aureus in various population groups from a rural and semi urban area in Gabon, Central Africa. Acta Trop (2012) 1.01
Reasons for non-adherence to vaccination at mother and child care clinics (MCCs) in Lambaréné, Gabon. Vaccine (2009) 1.00
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med (2015) 0.99
DNA phasing by TA dinucleotide microsatellite length determines in vitro and in vivo expression of the gp91phox subunit of NADPH oxidase and mediates protection against severe malaria. J Infect Dis (2004) 0.97
Uncommon asymptomatic Plasmodium falciparum infections in Gabonese children. Clin Infect Dis (2003) 0.97
Immunoglobulin G isotype responses to variant surface antigens of Plasmodium falciparum in healthy Gabonese adults and children during and after successive malaria attacks. Infect Immun (2004) 0.97
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children. Malar J (2011) 0.96
Randomized, controlled, assessor-blind clinical trial to assess the efficacy of single- versus repeated-dose albendazole to treat ascaris lumbricoides, trichuris trichiura, and hookworm infection. Antimicrob Agents Chemother (2014) 0.96
Influence of carriage of hemoglobin AS and the Fc gamma receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children. J Infect Dis (2005) 0.96
A longitudinal study of allergy and intestinal helminth infections in semi urban and rural areas of Flores, Indonesia (ImmunoSPIN Study). BMC Infect Dis (2011) 0.96
Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines. Clin Infect Dis (2002) 0.94
Evidence for the efficacy of artesunate in asymptomatic Plasmodium malariae infections. J Antimicrob Chemother (2002) 0.93
Ficolin-2 levels and genetic polymorphisms of FCN2 in malaria. Hum Immunol (2010) 0.92
Buruli ulcer in Gabon, 2001-2010. Emerg Infect Dis (2012) 0.92
Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria. Malar J (2008) 0.91
Phase I randomized dose-ascending placebo-controlled trials of ferroquine--a candidate anti-malarial drug--in adults with asymptomatic Plasmodium falciparum infection. Malar J (2011) 0.91
Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children. Clin Infect Dis (2003) 0.90
Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes. BMC Genet (2010) 0.89
Endoglin in African children with Plasmodium falciparum malaria: a novel player in severe malaria pathogenesis? J Infect Dis (2009) 0.86
Clinical, environmental, and serologic surveillance studies of melioidosis in Gabon, 2012-2013. Emerg Infect Dis (2015) 0.85
Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients. Antimicrob Agents Chemother (2002) 0.84
Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections. Antimicrob Agents Chemother (2012) 0.83
Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection. Malar J (2009) 0.83
Limit of blank and limit of detection of Plasmodium falciparum thick blood smear microscopy in a routine setting in Central Africa. Malar J (2014) 0.83
NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. Malar J (2008) 0.81
Haematological and biochemical reference intervals for infants and children in Gabon. Trop Med Int Health (2010) 0.81
Malaria in pregnancy in rural Gabon: a cross-sectional survey on the impact of seasonality in high-risk groups. Malar J (2013) 0.80
Developing information technology at the Medical Research Unit of the Albert Schweitzer Hospital in Lambaréné, Gabon. Wien Klin Wochenschr (2010) 0.79
The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel. Malar J (2011) 0.78
Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double-blind, placebo-controlled trial. Malar J (2008) 0.78
Medical research at the Albert Schweitzer Hospital. Wien Klin Wochenschr (2010) 0.77
In-vitro characterization of novel and functional regulatory SNPs in the promoter region of IL2 and IL2R alpha in a Gabonese population. BMC Med Genet (2012) 0.75
Assessment of LED fluorescence microscopy for the diagnosis of Plasmodium falciparum infections in Gabon. Malar J (2011) 0.75
A pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary schistosomiasis. Genet Test Mol Biomarkers (2012) 0.75